姓名：季俐俐
职称：副教授
个人简介：江苏南通人，医学博士。
专业研究领域：基础医学、肿瘤病理、肺癌增殖与耐药研究。
专著与论集：
1. Ji Lili#*, Moghal Nadeem, Zou Xinru, Fang Yixuan, Hu Shuning, Wang Yuhui, Tsao Ming Sound; The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells, Cancer Med 2022.
2. Fang Yixuan; Zou Xinru; Hu Shuning; Ji Lili*; Progress of NRF2 Signaling Pathway in Promoting Proliferation of Non-small Cell Lung Cancer, Chinese journal of lung cancer, 2022,25(10): 735-741.
3. Ji Lili#*; Zhang Rui#; Chen Jie; Xue Qun; Moghal Nadeem; Tsao Ming Sound; PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC, Scientific Reports, 2019, 9: 12437.
4. Zhang Rui#; Gu Jun#; Chen Jie; Ni Jun; Hung Jieru; Wang Zhiwen; Zhang Xiaochen; Feng Jian*; Ji Lili*; High expression of PINK1 promotes proliferation and chemoresistance of NSCLC, Oncology Reports, 2017, 37(4): 2137-2146.
5. Wang Shuo#; Chen Yingying#; Li Yupeng; Gu Jun; Gu Shudong; Shi Hai; Li Xuesong; Lu Xiaoning; Li Xiang; Zhang Shuanglong; Yu Kangjun; Liu Kun*; Ji Lili*; DISC1 overexpression promotes non-small cell lung cancer cell proliferation, Oncotarget, 2017, 8(39): 65199-65210.
6. Chen Jie#; Gu Jun#; Feng Jian; Liu Yifei; Xue Qun; Ni Tingting; Wang Zhiwen; Jia Liangliang; Mao Guoxin*; Ji Lili*; TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-kappaB pathway, Tumor Biology, 2016, 37(3): 3851-3861.
7. Liu Kun#; Wang Shuo#; Liu Yifei; Gu Jun; Gu Shudong; Xu Zhen; Zhang Rui; Wang Zhiwen; Ma Huaci; Chen Yingying; Ji Lili*; Overexpression of MYCN promotes proliferation of non-small cell lung cancer, Tumor Biology, 2016, 37(9): 12855-12866.
主要科研项目
主持及参与多项科研项目，其中主持的项目包括国家自然科学基金项目1项，江苏省高校面上项目1项、南通市科技计划项目2项。
讲授课程
病理学、
指导研究生情况
已毕业硕士生2名，；在读硕士研究生1名。